Literature DB >> 25894774

Effects of antibiotic treatment on the lactobacillus composition of vaginal microbiota.

A R Melkumyan1, T V Priputnevich, A S Ankirskaya, V V Murav'eva, L A Lubasovskaya.   

Abstract

We analyzed sensitivity of 123 vaginal lactobacillus strains to antibacterial substances. All lactobacillus strains were sensitive to ampicillin, cefazolin, cefotaxime, and vancomycin, and insensitive to metronidazole, trimethoprim/sulfamethoxazole, and levofloxacin. Lactobacillus strains demonstrated different sensitivity to gentamycin, clindamycin, erythromycin, ciprofloxacin, and tetracycline. The phenomenon of preferential selective influence of antibacterial drugs on the composition of lactobacilli of the vaginal microbiota, in which some lactobacilli survive as part of the vaginal microbiota and have a selective advantage over other types of lactobacilli, should be taken into account during treatment of vaginal infections and dysbiosis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25894774     DOI: 10.1007/s10517-015-2857-1

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  10 in total

Review 1.  Effects of Pro/Prebiotics Alone over Pro/Prebiotics Combined with Conventional Antibiotic Therapy to Treat Bacterial Vaginosis: A Systematic Review.

Authors:  Roghayeh Afifirad; Amir Darb Emamie; Rezvan Golmoradi Zadeh; Parisa Asadollahi; Roya Ghanavati; Atieh Darbandi
Journal:  Int J Clin Pract       Date:  2022-04-21       Impact factor: 3.149

Review 2.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

3.  Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.

Authors:  Toril Andersen; Ekaterina Mishchenko; Gøril Eide Flaten; Johanna U Ericson Sollid; Sofia Mattsson; Ingunn Tho; Nataša Škalko-Basnet
Journal:  Mar Drugs       Date:  2017-03-04       Impact factor: 5.118

4.  d-Alanyl-d-Alanine Ligase as a Broad-Host-Range Counterselection Marker in Vancomycin-Resistant Lactic Acid Bacteria.

Authors:  Shenwei Zhang; Jee-Hwan Oh; Laura M Alexander; Mustafa Özçam; Jan-Peter van Pijkeren
Journal:  J Bacteriol       Date:  2018-06-11       Impact factor: 3.490

5.  Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.

Authors:  Marijn C Verwijs; Stephen K Agaba; Alistair C Darby; Janneke H H M van de Wijgert
Journal:  Am J Obstet Gynecol       Date:  2019-08-09       Impact factor: 8.661

6.  Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study.

Authors:  Christopher J Martoni; Amalie Kruse Sigersted Frederiksen; Anders Damholt; Gregory Leyer
Journal:  Int J Womens Health       Date:  2022-01-18

7.  Evaluation of vaginal microbiota in women admitted to the hospital for premature labour.

Authors:  Bruno Arena; Maria Diletta Daccò
Journal:  Acta Biomed       Date:  2021-11-03

8.  Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer.

Authors:  David Jacobson; Kathleen Moore; Camille Gunderson; Michelle Rowland; Rita Austin; Tanvi Prasad Honap; Jiawu Xu; Christina Warinner; Krithivasan Sankaranarayanan; Cecil M Lewis
Journal:  PeerJ       Date:  2021-06-17       Impact factor: 2.984

9.  Ethyl Pyruvate: An Anti-Microbial Agent that Selectively Targets Pathobionts and Biofilms.

Authors:  Tewodros Debebe; Monika Krüger; Klaus Huse; Johannes Kacza; Katja Mühlberg; Brigitte König; Gerd Birkenmeier
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

10.  Treatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin.

Authors:  Thor Haahr; Helle O Elbaek; Rita J Laursen; Birgit Alsbjerg; Jørgen S Jensen; Peter Humaidan
Journal:  Front Physiol       Date:  2017-06-19       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.